Blended learning for entrepreneurial biomedical professionals

Paul Janssen Futurelab Leiden offers a non-profit, international blended learning program for tomorrow’s leaders in biomedical science who have the ambition to develop a new medical intervention.

white paper

Take the next step in your biomedical career

Do you have a great idea for a new medical product, but no idea where to start developing it? The trick is to find a post-graduate training program that is suited to your specific needs.

That's why we wrote a white paper about the Future4 approach to help you find the right post-graduate program by identifying the four key focus areas that will take your career to the next level.


Get access to our white paper

On campus

On-campus experience

Further explore the concepts of the online courses during the on-campus course. Maximum 30 participants are invited to castle Oud-Poelgeest near Leiden, the Netherlands to work in small, multidisciplinary focus groups on advanced teaching cases that are based on real R&D project.


Read more

A selection of our contributors

Juliane Bernholz

Juliane Bernholz

Chief Operating Officer


AM Pharma

Onno van de Stolpe

Onno van de Stolpe

Former CEO


Galapagos

Marc Martens

Marc Martens

Head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels


Bird & Bird

Aliki Nichogiannopoulou

Aliki Nichogiannopoulou

Director


European Patent Office

Ton van der Hoven

Ton van der Hoven

CEO


SurgVision BV

Bruno Vandermeulen

Bruno Vandermeulen

IP Lawyer - Member of the Brussels Bar


Independent IP practitioner

On-campus

Nacer Lounis

Nacer Lounis

Senior Principal Scientist


Janssen Pharmaceutica

On-campus

Tine de Marez

Tine de Marez

Senior Director, Compound Development Team Leader TB


Johnson & Johnson

Bert Leufkens

Bert Leufkens

Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board


Utrecht Institute for Pharmaceutical Sciences (UIPS)

Henk Schuring

Henk Schuring

VP-Head Rare Nephrology


Prilenia

Sjaak Bot

Sjaak Bot

Former VP, Head of EMEA Regulatory Affairs


Janssen

Bernd van der Meulen

Bernd van der Meulen

Professor of Comparative Food Law


European Institute for Food Law / Renmin University of China Law School

Frank Landolt

Frank Landolt

Chief Counsel Legal & Intellectual Property


Confo Therapeutics

On-campus

Erik Niks

Erik Niks

Neurologist - Pediatric neurologist


Leiden University Medical Center

On-campus

Piet Hinoul

Piet Hinoul

Chief Medical Officer


Virtual Incision

On-campus

Ad Sitsen

Ad Sitsen

Owner


ClinPharMed Consultancy for Drug Development

Eline Bunnik

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine


Erasmus MC

Maurits Westerik

Maurits Westerik

IE/IT lawyer


Coupry

Bart Swinkels

Bart Swinkels

Partner


NLO

Karin Verzijden

Karin Verzijden

Food and Pharma Lawyer


Axon Lawyers

On-campus

Ineke Jonker-Hoogerkamp

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development


Paul Janssen Futurelab & Eagle Pharma Consult

Kees Recourt

Kees Recourt

Investment Manager


Mibiton Foundation

Paul Stoffels

Paul Stoffels

CEO


Galapagos

On-campus

Marcel Kenter

Marcel Kenter

Director


Paul Janssen Futurelab Leiden

On-campus

Koen Andries

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery


Janssen Pharmaceutica NV

On-campus

Andreas Wallnöfer

Andreas Wallnöfer

General Partner


BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

On-campus

André Elferink

André Elferink

Clinical epidemiologist


Dutch Medicines Evaluation Board

Hans-Georg Eichler

Hans-Georg Eichler

Senior Medical Officer


European Medicines Agency

Inge de Lepeleire

Inge de Lepeleire

Director Translational Pharmacology


MSD Europe

Johan Garssen

Johan Garssen

Director Immunology Platform


Danone/Nutricia Research

Rick Kuntz

Rick Kuntz

Former Senior Vice President and Chief Scientific, Clinical and Regulatory Officer


Medtronic

Oliver Bisazza

Oliver Bisazza

Former Director Regulatory Policy


Medtronic

Saco de Visser

Saco de Visser

Teacher and Clinical Pharmacologist


Paul Janssen Futurelab Leiden

Richard Shull

Richard Shull

Head of Deal Structuring and Trading Fundamentals


Shell

Pierre Peeters

Pierre Peeters

Early Clinical Development Expert


Curare Consulting

Quote Paul Janssen Futurelab

Interesting insights

Very nice approach, all cases were well explained in the provided papers and the interviews always gave interesting insights.

Pierre-Eric Juif, Actelion, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Very relevant contemporary cases

The online Market Approval course is a very interesting and useful course, I enjoyed it a lot! Especially the relevant and contemporary cases really were of additional value.

Anna van Muyden, Director clinical development, CellPoint

Quote Paul Janssen Futurelab

Happy with responses

“Real life case studies and learning about 'how it really happened'. Very happy with responses on comments (timewise and content)”

Joost van Middendorp, Pfizer, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Increase your knowledge on intellectual property

As a project manager working in the biotech sector, I can really recommend this course to increase your knowledge on intellectual property. The course guides you through the IP process and gives numerous interesting and practical examples

Charlotte Berendsen, Senior Associate, Research Program Management Genmab B.V.